<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-07-01T13:46:29.4628+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:aktx="http://www.akaritx.com/20240628" xmlns:calc="https://xbrl.org/2023/calculation-1.1" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_bbdf24ab-0d70-4982-8fb3-9aa0862e049c" name="dei:AmendmentFlag" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_12941a32-70ae-4da4-ac56-5cedb2931f40" name="dei:EntityCentralIndexKey" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec">0001541157</ix:nonNumeric><ix:nonNumeric id="F_f49f9c23-1349-4033-a725-25f4e89cb63c" name="dei:NoTradingSymbolFlag" contextRef="C_becf644d-e148-40a3-baf8-5fe4a2690c7f">true</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="aktx-20240628.xsd"/></ix:references><ix:resources><xbrli:context id="C_becf644d-e148-40a3-baf8-5fe4a2690c7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001541157</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aktx:OrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-28</xbrli:startDate><xbrli:endDate>2024-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2eb57bca-8269-4f55-abe4-fb5ad2c354db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001541157</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">dei:AdrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-28</xbrli:startDate><xbrli:endDate>2024-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3dbc7784-483c-43e2-8614-bb99cf2562ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001541157</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-28</xbrli:startDate><xbrli:endDate>2024-06-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9889eec9-e60f-4784-bd15-cb462237a097" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">d</span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">) of the<br/>Securities Exchange Act of 1934</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date of Report (Date of earliest event reported):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a7e77b26-fc56-4fb0-9d01-358206661aa4" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">June 28, 2024</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:16pt;font-family:Times New Roman;"><ix:nonNumeric id="F_820e3eba-0498-4483-8751-944c86569ca5" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;">Akari Therapeutics, Plc</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Exact Name of Registrant as Specified in Charter)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:33%;"/>
    <td style="width:1%;"/>
    <td style="width:32%;"/>
    <td style="width:1%;"/>
    <td style="width:33%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_13d545c6-ae4c-4651-a513-b9524569c616" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">England and Wales</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;padding-bottom:0.014in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_19878e25-8357-4d6f-ad3b-441ccc172d0e" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-36288</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;padding-bottom:0.014in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d9294e43-cb28-4fb8-ad97-55ab1d1fb1d8" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">98-1034922</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(State or other jurisdiction <br/>of incorporation)</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(I.R.S. Employer<br/>Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_72b1abaa-6715-464b-9977-8e9dd90b928d" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">22 Boston Wharf Road FL 7</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7fee8fa5-23c1-43e4-af11-22932e6da3c4" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Boston</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7cd1c7fc-1957-4126-ae95-a2faca048edb" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">MA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ae73a576-fb49-488c-90b4-c865e3ff4ba2" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">02210</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Address, including zip code, of Principal Executive Offices)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d8a342c0-0b8f-4243-be0d-fe763bf21890" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">929</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1ab38d6f-9032-453d-afe8-6c41342498ab" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">274-7510</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.84%;"/>
    <td style="width:96.16%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Wingdings',serif;"><ix:nonNumeric id="F_43600e4b-429b-4efa-bf17-562588d4fff8" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:WrittenCommunications" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#168;</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Wingdings',serif;"><ix:nonNumeric id="F_0a84e7a6-1996-4f8a-b172-f18139a7c416" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:SolicitingMaterial" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#168;</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Wingdings',serif;"><ix:nonNumeric id="F_c34b9cd4-9a6c-4de1-844c-d52027684be9" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#168;</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Wingdings',serif;"><ix:nonNumeric id="F_e74b27ad-1e9e-4f05-b2b9-142683e07d4d" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#168;</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:39.94%;"/>
    <td style="width:1%;"/>
    <td style="width:18%;"/>
    <td style="width:1%;"/>
    <td style="width:40.06%;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="vertical-align:bottom;border-bottom:1pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Title of each class:</span></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:bottom;border-bottom:1pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Name of each</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_15860025-b4c2-4c9e-8fbd-d7857f109a72" contextRef="C_2eb57bca-8269-4f55-abe4-fb5ad2c354db" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">American Depositary Shares, each representing 2,000 Ordinary Shares</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_a8715d59-6564-4481-8a46-0a1088b77b3a" contextRef="C_2eb57bca-8269-4f55-abe4-fb5ad2c354db" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">AKTX</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The </span><span><ix:nonNumeric id="F_e7bb6611-f0c2-4e91-8314-45fa93eec33a" contextRef="C_2eb57bca-8269-4f55-abe4-fb5ad2c354db" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;Capital Market</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_35c65cf9-dc65-4dd4-a881-59bedcf427cc" contextRef="C_becf644d-e148-40a3-baf8-5fe4a2690c7f" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Ordinary Shares, par value $0.0001 per share*</span></ix:nonNumeric></span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">*Trading, but only in connection with the American Depositary Shares.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;font-family:'Wingdings',serif;"><ix:nonNumeric id="F_061b8e0a-5ae9-4e06-b56b-d52ba3143e6a" contextRef="C_3dbc7784-483c-43e2-8614-bb99cf2562ec" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Wingdings',serif;min-width:fit-content;">&#168;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Wingdings',serif;min-width:fit-content;">&#168;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="page-break-after:always;"/>
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5.07  Submission of Matters to a Vote of Security Holders.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 27, 2024, Akari Therapeutics, Plc (the &#8220;Company&#8221;) held its 2024 Annual General Meeting (the &#8220;Annual General Meeting&#8221;). Proxies were solicited pursuant to the Company&#8217;s definitive proxy statement filed on June 3, 2024 (the &#8220;Proxy Statement&#8221;), with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended. The number of ordinary shares entitled to vote at the Annual General Meeting was 15,847,391,523. The number of ordinary shares present or represented by valid proxy at the Annual General Meeting failed to establish a quorum for the Annual General Meeting. Accordingly, the Annual General Meeting was adjourned to June 28, 2024 (the &#8220;Adjourned Annual General Meeting&#8221;). The Adjourned Annual General Meeting duly proceeded in accordance with the provisions of the articles of association of the Company and all matters submitted to a vote of the Company&#8217;s shareholders at the Adjourned Annual General Meeting were approved and the director nominees were elected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The voting results below are final and reported in ordinary shares.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:35%;"/>
    <td style="width:16%;"/>
    <td style="width:17%;"/>
    <td style="width:16%;"/>
    <td style="width:16%;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;text-indent:3.3pt;border-left:1pt solid;padding-right:0.05in;"><p style="margin-left:3.3pt;text-indent:0;font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Ordinary Resolution</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.09513888888888888in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Votes For</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.013194444444444444in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Votes Against</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.029166666666666667in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Votes Withheld</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.029166666666666667in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Broker Non-Votes</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To receive the report of the Board of Directors and the accounts for the year ended December 31, 2023, together with the report of the statutory auditor and the strategic report.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">6,311,484,728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">33,260</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.003472222222222222in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">138,680,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To approve the Board of Directors&#8217; Remuneration Report (excluding the Board of Directors&#8217; Remuneration Policy), as set out in the Company&#8217;s annual report and accounts for the financial year ended December 31, 2023.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">6,303</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">638,728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009027777777777779in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">36,882,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">142,904</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.0076388888888888895in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To re-elect Donald Williams as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Company&#8217;s articles of association (the &#8220;Articles&#8221;).</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">5</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">692</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">126</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.008333333333333333in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">747,748,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">43</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">550</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.0076388888888888895in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To re-elect Michael Grissinger as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Articles.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">6</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">276,194</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">204,180,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">3</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">050</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To re-elect Mohamed Wa&#8217;El Ahmed Hashad as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Articles.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">5,687,886,728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">691</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">988</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">103</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">550</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To re-elect Samir Patel as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Articles.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">6,473</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">892</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.944444444444445E-4in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">5</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">982</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">3</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">550</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To re-elect Raymond Prudo-Chlebosz, M.D. as a director of Akari, as a Class C Director as stated in Article 18.2.3 of the Articles.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">6,436,330,728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.009027777777777779in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">43,854,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">3</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">240</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To ratify the appointment of BDO USA, P.C. as independent registered public accounting firm of Akari for the year ending December 31, 2024.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">6,409,914,728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.5pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.0076388888888888895in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">716,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.014583333333333334in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">72,794,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To ratify the appointment of Haysmacintyre LLP as statutory auditors of Akari to hold office until the conclusion of the next annual general meeting at which accounts are laid before Akari shareholders.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">6,440</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">226</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:6.944444444444445E-4in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">930</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.0020833333333333333in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">42</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">268</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
  </table>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="page-break-after:always;"/>
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:35%;"/>
    <td style="width:16%;"/>
    <td style="width:17%;"/>
    <td style="width:16%;"/>
    <td style="width:16%;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="border-top:1pt solid #000000;padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To authorize the audit committee of the Board of Directors of Akari to fix the statutory auditors&#8217; remuneration.</span></p></td>
    <td style="border-top:1pt solid #000000;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">6,440,856</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">728</span></p></td>
    <td style="border-top:1pt solid #000000;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.011111111111111112in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">3,826,000</span></p></td>
    <td style="border-top:1pt solid #000000;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.010416666666666666in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">38,742,000</span></p></td>
    <td style="border-top:1pt solid #000000;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.020138888888888887in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To approve, on a non-binding, advisory basis, the compensation of our named executive officers (&#8220;NEOs&#8221;) as disclosed in the Proxy Statement.</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">6</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">335</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">386</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.015277777777777779in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">7,448,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">140</span><span style="color:#606060;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">590</span><span style="color:#494949;white-space:pre-wrap;min-width:fit-content;">,</span><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:35%;"/>
    <td style="width:13%;"/>
    <td style="width:13%;"/>
    <td style="width:13%;"/>
    <td style="width:13%;"/>
    <td style="width:13%;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;text-indent:3.3pt;border-left:1pt solid;padding-right:0.05in;"><p style="margin-left:3.3pt;text-indent:0;font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Ordinary Resolution</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.09513888888888888in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1 Year</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.013194444444444444in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2 Year</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.029166666666666667in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3 Year</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.029166666666666667in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Abstain</span></p></td>
    <td style="border-top:1pt solid;padding-top:0.05in;border-right:1pt solid;padding-left:0.05in;vertical-align:bottom;padding-bottom:0.05in;border-bottom:1pt solid;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0.8pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.029166666666666667in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Broker Non-Votes</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.05in;border-right:1pt solid #000000;border-left:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">To indicate, on a non-binding, advisory basis, the preferred frequency of future shareholder advisory votes on the compensation of Akari&#8217;s NEOs.</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">4,610,354,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">1,866,410,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.003472222222222222in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">2,676,728</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1.25pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.003472222222222222in;text-align:center;"><span style="color:#2b2b2b;white-space:pre-wrap;min-width:fit-content;">3,984,000</span></p></td>
    <td style="padding-top:0.05in;border-right:1pt solid #000000;padding-left:0.05in;vertical-align:top;padding-bottom:0.05in;border-bottom:1pt solid #000000;padding-right:0.05in;text-align:left;"><p style="font-size:9pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.001388888888888889in;text-align:center;"><span style="color:#1a1a1a;white-space:pre-wrap;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on these results and consistent with the Company&#8217;s recommendation, the Company will conduct future advisory votes regarding the compensation of the Company&#8217;s NEOs on an annual basis. This policy will remain in effect until the next stockholder vote on the frequency of such advisory votes.<br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="page-break-after:always;"/>
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:36.593%;"/>
    <td style="width:3.539%;"/>
    <td style="width:59.868%;"/>
   </tr>
   <tr style="height:17pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Akari Therapeutics, Plc</span></p></td>
   </tr>
   <tr style="height:17pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:15.75pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date: July 1, 2024</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span></p></td>
    <td style="vertical-align:top;border-bottom:0.75pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Samir R. Patel, M.D.</span></p></td>
   </tr>
   <tr style="height:13.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Samir R. Patel, M.D.</span></p></td>
   </tr>
   <tr style="height:17pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Interim President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8203;</span></p>
  <div class="page-node-content"><div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "aktx-20240628.htm", "description": "8-K", "secsgml_size_bytes": 83130}]
{"company-data": {"conformed-name": "Akari Therapeutics Plc", "cik": "0001541157", "assigned-sic": "2834", "organization-name": "03 Life Sciences", "irs-number": "981034922", "state-of-incorporation": "X0"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36288", "film-number": "241091043"}, "business-address": {"street1": "22 BOSTON WHARF ROAD", "street2": "FL 7", "city": "BOSTON", "state": "MA", "zip": "02210", "phone": "(646) 350-0702"}, "mail-address": {"street1": "22 BOSTON WHARF ROAD", "street2": "FL 7", "city": "BOSTON", "state": "MA", "zip": "02210"}, "former-company": [{"former-conformed-name": "Celsus Therapeutics Plc.", "date-changed": "20130621"}, {"former-conformed-name": "Morria Biopharmaceuticals PLC", "date-changed": "20120201"}]}
8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(
d
) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 28, 2024
Akari Therapeutics, Plc
(Exact Name of Registrant as Specified in Charter)
England and Wales
001-36288
98-1034922
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
22 Boston Wharf Road FL 7
Boston
,
MA
02210
(Address, including zip code, of Principal Executive Offices)
Registrant's telephone number, including area code: (
929
)
274-7510
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
Trading Symbol(s)
Name of each
exchange on which registered
American Depositary Shares, each representing 2,000 Ordinary Shares
AKTX
The
Nasdaq
Capital Market
Ordinary Shares, par value $0.0001 per share*
*Trading, but only in connection with the American Depositary Shares.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 5.07  Submission of Matters to a Vote of Security Holders.
On June 27, 2024, Akari Therapeutics, Plc (the "Company") held its 2024 Annual General Meeting (the "Annual General Meeting"). Proxies were solicited pursuant to the Company's definitive proxy statement filed on June 3, 2024 (the "Proxy Statement"), with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended. The number of ordinary shares entitled to vote at the Annual General Meeting was 15,847,391,523. The number of ordinary shares present or represented by valid proxy at the Annual General Meeting failed to establish a quorum for the Annual General Meeting. Accordingly, the Annual General Meeting was adjourned to June 28, 2024 (the "Adjourned Annual General Meeting"). The Adjourned Annual General Meeting duly proceeded in accordance with the provisions of the articles of association of the Company and all matters submitted to a vote of the Company's shareholders at the Adjourned Annual General Meeting were approved and the director nominees were elected.
The voting results below are final and reported in ordinary shares.
Ordinary Resolution
Votes For
Votes Against
Votes Withheld
Broker Non-Votes
To receive the report of the Board of Directors and the accounts for the year ended December 31, 2023, together with the report of the statutory auditor and the strategic report.
6,311,484,728
33,260
,
000
138,680,000
–
To approve the Board of Directors' Remuneration Report (excluding the Board of Directors' Remuneration Policy), as set out in the Company's annual report and accounts for the financial year ended December 31, 2023.
6,303
,
638,728
36,882,000
142,904
,
000
–
To re-elect Donald Williams as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Company's articles of association (the "Articles").
5
,
692
,
126
,
728
747,748,000
43
,
550
,
000
–
To re-elect Michael Grissinger as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Articles.
6
,
276,194
,
728
204,180,000
3
,
050
,
000
–
To re-elect Mohamed Wa'El Ahmed Hashad as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Articles.
5,687,886,728
691
,
988
,
000
103
,
550
,
000
–
To re-elect Samir Patel as a director of Akari, as a Class A Director as stated in Article 18.2.1 of the Articles.
6,473
,
892
,
728
5
,
982
,
000
3
,
550
,
000
–
To re-elect Raymond Prudo-Chlebosz, M.D. as a director of Akari, as a Class C Director as stated in Article 18.2.3 of the Articles.
6,436,330,728
43,854,000
3
,
240
,
000
–
To ratify the appointment of BDO USA, P.C. as independent registered public accounting firm of Akari for the year ending December 31, 2024.
6,409,914,728
716,000
72,794,000
–
To ratify the appointment of Haysmacintyre LLP as statutory auditors of Akari to hold office until the conclusion of the next annual general meeting at which accounts are laid before Akari shareholders.
6,440
,
226
,
728
930
,
000
42
,
268
,
000
–
To authorize the audit committee of the Board of Directors of Akari to fix the statutory auditors' remuneration.
6,440,856
,
728
3,826,000
38,742,000
–
To approve, on a non-binding, advisory basis, the compensation of our named executive officers ("NEOs") as disclosed in the Proxy Statement.
6
,
335
,
386
,
728
7,448,000
140
,
590
,
000
–
Ordinary Resolution
1 Year
2 Year
3 Year
Abstain
Broker Non-Votes
To indicate, on a non-binding, advisory basis, the preferred frequency of future shareholder advisory votes on the compensation of Akari's NEOs.
4,610,354,000
1,866,410,000
2,676,728
3,984,000
–
Based on these results and consistent with the Company's recommendation, the Company will conduct future advisory votes regarding the compensation of the Company's NEOs on an annual basis. This policy will remain in effect until the next stockholder vote on the frequency of such advisory votes.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Akari Therapeutics, Plc
Date: July 1, 2024
By:
/s/ Samir R. Patel, M.D.
Samir R. Patel, M.D.
Interim President and Chief Executive Officer
​